Redefining Colorectal Cancer by Tumor Biology.

Redefining Colorectal Cancer by Tumor Biology.
复制标题

通过肿瘤生物学重新定义结直肠癌。

DOI:
10.1200/edbk_279867
复制
发表时间:
2020
期刊:
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
影响因子:
--
通讯作者:
J. Tie
J. Tie
中科院分区:
--
文献类型:
--
作者:
M. Salem;A. Puccini;J. Tie

文献摘要

参考文献

被引文献

相似文献

Colorectal cancer treatment has undergone a paradigm shift. We no longer see this disease as a singular, anatomic tumor type but rather a set of disease subgroups. Largely because of a better understanding of cancer biology and the introduction and integration of molecular biomarkers-the premise of precision therapy-we are beginning to direct treatments toward the right tumor target(s) in the right patients. The field of molecular profiling is continually evolving, and new biomarkers are constantly being discovered that have investigational, therapeutic, and/or prognostic implications-negative or positive. To date, only a few biomarkers have sufficient actionable, clinical implication to earn international guideline-recommended routine testing. Hence, it is vital that the treating oncologist should know which biomarkers to assess, when in the treatment course to test for them, and how the test is to be done. Correct interpretation of profiling results is imperative. Herein, we focus on international guideline-recommended mutation testing for patients prior to their colorectal cancer treatment initiation. The clinical applications of circulating tumor DNA (ctDNA) in patients with metastatic disease, based on our current knowledge and capabilities, are also addressed.
DOI: 10.1053/j.gastro.2009.12.064
发表时间: 2010-06
期刊: Gastroenterology
影响因子: 29.4
作者:
Boland CR;Goel A
通讯作者: Goel A
DOI: 10.1158/2159-8290.cd-12-0558
发表时间: 2013-06
期刊: Cancer discovery
影响因子: 28.2
作者:
Bardelli A;Corso S;Bertotti A;Hobor S;Valtorta E;Siravegna G;Sartore-Bianchi A;Scala E;Cassingena A;Zecchin D;Apicella M;Migliardi G;Galimi F;Lauricella C;Zanon C;Perera T;Veronese S;Corti G;Amatu A;Gambacorta M;Diaz LA Jr;Sausen M;Velculescu VE;Comoglio P;Trusolino L;Di Nicolantonio F;Giordano S;Siena S
通讯作者: Siena S
DOI: 10.1056/nejmoa043146
发表时间: 2005-05-05
影响因子: 158.5
作者:
Hampel, H;Frankel, WL;Papadopoulos, N
通讯作者: Papadopoulos, N
DOI: 10.1158/2159-8290.cd-15-1283
发表时间: 2016-02
期刊: Cancer discovery
影响因子: 28.2
作者:
Russo M;Siravegna G;Blaszkowsky LS;Corti G;Crisafulli G;Ahronian LG;Mussolin B;Kwak EL;Buscarino M;Lazzari L;Valtorta E;Truini M;Jessop NA;Robinson HE;Hong TS;Mino-Kenudson M;Di Nicolantonio F;Thabet A;Sartore-Bianchi A;Siena S;Iafrate AJ;Bardelli A;Corcoran RB
通讯作者: Corcoran RB
DOI: 10.1158/2159-8290.cd-17-1226
发表时间: 2018-04
期刊: Cancer discovery
影响因子: 28.2
作者:
Corcoran RB;André T;Atreya CE;Schellens JHM;Yoshino T;Bendell JC;Hollebecque A;McRee AJ;Siena S;Middleton G;Muro K;Gordon MS;Tabernero J;Yaeger R;O'Dwyer PJ;Humblet Y;De Vos F;Jung AS;Brase JC;Jaeger S;Bettinger S;Mookerjee B;Rangwala F;Van Cutsem E
通讯作者: Van Cutsem E